Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity

Journal of Molecular Biology

Volumn 311, Issue 1, 2001, Pages 173-182

  Chen, Songming ^a   Berthelier, Valerie ^a   Yang, Wen ^a   Wetzel, Ronald ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Aggregation; Huntington's disease; Inclusion; Nucleation; Polyglutamine

Indexed keywords

CELL PROTEIN; POLYGLUTAMINE;

ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CYTOTOXICITY; HUNTINGTON CHOREA; IN VITRO STUDY; MORPHOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROCESSING; STRUCTURE ANALYSIS; THERMODYNAMICS;

EID: 0035800572     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4850     Document Type: Article

References (54)

1. Fourteen and counting: Unraveling trinucleotide repeat diseases
2. Huntington's disease
3. Recent advances in understanding the pathogenesis of Huntington's disease
4. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
5. Polyglutamine diseases: Protein cleavage and aggregation
6. Recruitment and the role of nuclear localization in polyglutamine-mediated, aggregation
7. Evidence for a recruitment and sequestration mechanism in Huntington's disease
8. Glutamme repeats and inherited neurodegenerative diseases: Molecular aspects
9. Cellular defects and altered gene expression in PC12 cells stably expressing mutant huntingtin
10. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1
11. Transcriptional dysregulation in Huntington's disease
12. Self-assembly of polyglutamine-containing hunfingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
13. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3
14. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
15. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells
16. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
17. CREB-binding protein sequestration by expanded polyglutamine
18. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
19. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
20. Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides
21. Peptide models for inherited neurode-generative disorders: Conformation and aggregation properties of long polyglutamine peptides with and without interruptions
22. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
23. Solubilization and disaggregation of polyglutamine peptides
24. The β sheet-coil transition of polypeptides, as determined by circular dichroism
25. Theory of circular dichroism of proteins
26. Quantification of β-sheet amyloid fibril structures with thioflavin T
27. Amyloidosis
28. The self-assembly of long rodlike structures
29. Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway
30. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
31. Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E
32. Immunoassays with time-resolved fluorescence spectroscopy: Principles and applications
33. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism
34. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy
35. Molecular basis of the neurodegenerative disorders
36. The systemic amyloidoses
37. Normal and abnormal biology of the β-amyloid precursor protein
38. The role of accessory proteins in protein folding diseases
39. Putting the parkin into Parkinson's
40. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
41. Mad cows meet psi-chotic yeast: The expansion of the prion hypothesis
42. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: A new polyglutamine disease?
43. Genetics and molecular biology of the androgen receptor CAG repeat
44. Formation of neuronal intranuclear inclusions underlies the neurological dysftmction in mice transgenic for the HD mutafion
45. Diffusible, nonfibrillar ligands derived from Abetal-42 are potent central nervous system neurotoxins
46. Intracellular APP processing and A beta production in Alzheimer disease
47. Intracellular accumulation of insoluble, newly synthesized abetan-42 in amyloid precursor protein-transfected cells that have been treated with Abetal-42
48. Oligomeric Abeta in PBS-soluble extracts of human Alzheimer brain
49. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates
50. Quantifying the kinetic parameters of prion replication
51. For protein misassembly, it's the "I" decade
52. Methodological and chemical factors affecting amyloid-β amyloidogenicity
53. A microtiter plate assay for polyglutamine aggregate extension
54. An assay for characterizing the in vitro kinetics of polyglutamine aggregation